Literature DB >> 10321401

Family history taking and genetic counselling in primary care.

P Rose1, E Humm, K Hey, L Jones, S M Huson.   

Abstract

OBJECTIVES: We aimed to evaluate the feasibility and acceptability of taking routine family histories and subsequent counselling.
METHODS: The study was set in primary care in the UK. The subjects were patients between the ages of 20 and 34 years registered at one general practice. Patients were invited by letter to attend a clinic in their GP surgery, run by a GP and health visitor. A family history was constructed and counselling undertaken for any identified problems. A telephone survey of a sample of nonattenders was also performed. The outcome measures were attendance rate, patient views, patient anxiety as measured by the short form of the Spielberger State-Trait Anxiety Inventory and referrals to secondary care.
RESULTS: In total, 16.1% patients attended the clinic; 40.3 % had a family history of at least one disease with a possible genetic component. Anxiety levels fell immediately after the consultation and rose to pre-clinic levels at 12 weeks. The clinic generated three referrals to secondary care and a further seven patients who were counselled by the investigators following advice from a consultant geneticist.
CONCLUSIONS: It is possible to take detailed family histories and provide genetic counselling advice in primary care with minimal training of clinical primary care staff. The service is acceptable to patients, does not induce anxiety and has little effect on numbers of patients referred.

Entities:  

Mesh:

Year:  1999        PMID: 10321401     DOI: 10.1093/fampra/16.1.78

Source DB:  PubMed          Journal:  Fam Pract        ISSN: 0263-2136            Impact factor:   2.267


  14 in total

1.  Evaluation of questionnaire on cancer family history in general practice. Principal role of primary care is not to seek out those at increased genetic risk.

Authors:  J Emery
Journal:  BMJ       Date:  2000-01-15

2.  Improving the ascertainment of families at high risk of colorectal cancer: a prospective GP register study.

Authors:  Peter W Rose; Michael Murphy; Marcus Munafo; Cyril Chapman; Neil Mortensen; Anneke Lucassen
Journal:  Br J Gen Pract       Date:  2004-04       Impact factor: 5.386

3.  Family physician self-efficacy with screening for inherited cancer risk.

Authors:  Robert Gramling; Justin Nash; Karen Siren; Charles Eaton; Larry Culpepper
Journal:  Ann Fam Med       Date:  2004 Mar-Apr       Impact factor: 5.166

4.  Interactive genetic counseling role-play: a novel educational strategy for family physicians.

Authors:  Sean M Blaine; June C Carroll; Andrea L Rideout; Gord Glendon; Wendy Meschino; Cheryl Shuman; Deanna Telner; Natasha Van Iderstine; Joanne Permaul
Journal:  J Genet Couns       Date:  2008-01-30       Impact factor: 2.537

5.  The family history: An integral component of paediatric health assessment.

Authors:  Andrea L Shugar
Journal:  Paediatr Child Health       Date:  2003-01       Impact factor: 2.253

6.  Case 2: Making a diagnosis: Lest we forget the family.

Authors:  Mohsin Rashid
Journal:  Paediatr Child Health       Date:  2010-09       Impact factor: 2.253

7.  Healthcare Coordination and Transition for Individuals with Genetic Conditions.

Authors:  Sharon Romelczyk; Sharon Homan; Joseph Telfair; Gaurav Dave; Alisha Keehn; Deborah Maiese
Journal:  Matern Child Health J       Date:  2015-10

8.  A Prospective Comparison Study of Different Methods of Gathering Self-Reported Family History Information for Breast Cancer Risk Assessment.

Authors:  Caroline Benjamin; Katie Booth; Ian Ellis
Journal:  J Genet Couns       Date:  2003-04       Impact factor: 2.537

Review 9.  Preconception risk assessment for thalassaemia, sickle cell disease, cystic fibrosis and Tay-Sachs disease.

Authors:  Norita Hussein; Stephen F Weng; Joe Kai; Jos Kleijnen; Nadeem Qureshi
Journal:  Cochrane Database Syst Rev       Date:  2018-03-14

10.  GP-initiated preconception counselling in a randomised controlled trial does not induce anxiety.

Authors:  L C de Jong-Potjer; J Elsinga; S le Cessie; K M van der Pal-de Bruin; A Knuistingh Neven; S E Buitendijk; W J J Assendelft
Journal:  BMC Fam Pract       Date:  2006-11-03       Impact factor: 2.497

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.